Development Of Novel Folate Receptor (Fr)-Targeted Indenoisoquinoline Drug Delivery Systems (Ddss) Using Acid Sensitive N-Ethoxybenzylimidazole (Nebi) Crosslinkers For Anti-Cancer Therapy /